ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,339,000 | -92.0% | 28,900 | -95.8% | 0.05% | -91.9% |
| Q1 2019 | $16,728,000 | +166.3% | 686,100 | +55.6% | 0.58% | +140.1% |
| Q4 2018 | $6,282,000 | -22.3% | 440,800 | -17.1% | 0.24% | -32.6% |
| Q3 2018 | $8,082,000 | +60.8% | 531,700 | +77.5% | 0.36% | +31.5% |
| Q2 2018 | $5,026,000 | +145.8% | 299,500 | +139.0% | 0.27% | +78.4% |
| Q1 2018 | $2,045,000 | +1485.3% | 125,312 | +1146.3% | 0.15% | +1290.9% |
| Q4 2017 | $129,000 | -84.2% | 10,055 | -91.7% | 0.01% | -92.1% |
| Q3 2016 | $819,000 | – | 121,309 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |